# Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection

> **NCT02918955** · PHASE3 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 65 (actual)

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **PROCEDURE:** up-front neck dissection
- **RADIATION:** radiotherapy
- **DRUG:** Chemotherapy (Cisplatin)
- **PROCEDURE:** Early Salvage Neck Dissection in case of less than cCR (Arm A only)

## Key facts

- **NCT ID:** NCT02918955
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-16
- **Primary completion:** 2025-06-24
- **Final completion:** 2025-06-24
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918955, "Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02918955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*